About Contact Us Careers
Sign In

Protein Biochips Market Size & Share, by Technology (Microarrays, Microfluidics); End-user (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centres, Academic & Research Institutes) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 3257
  • Published Date: Oct 03, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024 - 2036.

Protein Biochips Market size is estimated to reach USD 36 Billion by the end of 2036, growing at a CAGR of 15% during the forecast period, i.e., 2023-2036. In the year 2023, the industry size of the protein biochips was around USD 8 Billion. The growth of the market can be attributed to the rising prevalence of chronic diseases, such as cancer which are increasing the demand for advanced diagnostic and therapeutic applications. As per the World Health Organization, nearly 10 million deaths in 2020 across the world were due to cancer. Protein biochips are small chips that contain proteins that can detect specific biomarkers associated with cancer.

Moreover, the advances in biochip technology, such as miniaturization and integration of sensors have enabled the development of more sensible and accurate protein biochips. There has been growing investment in research institutes that is expected to surge the need for protein biochips.

Protein Biochips Market
Get more information on this report: Request Free Sample PDF

Protein Biochips Sector: Growth Drivers and Challenges

Growth Drivers

  • Growing Diabetes Prevalence- Protein biochips are used to measure level of glucose and other proteins in the blood. This can be used to detect early signs of diabetes, which is becoming increasingly common owing to changes in lifestyle and diet. Nearly 37.3 million Americans have diabetes according to the Centers for Disease Control and Prevention. Additionally, protein biochips can be used to monitor the progression of diabetes and to ensure that patients are receiving proper treatment.
  • Intensified Funding for Pharmaceutical R&D Activities Across the Globe- A wide range of activities were covered by the costs, including medication research and testing, incremental enhancements, or expansions of products, and medical studies to monitor their safety. For instance, the US pharmaceutical companies spent more than USD 85 billion on research and development in 2019.
  • Rapid Emergence of Next-Generation Sequencing- The Next-Generation Sequencing NGS technology has revolutionized genomic research with its high throughput capabilities. Thousands to millions of molecules can be sequenced simultaneously using NGS methods as they are highly parallelized. Protein biochips are used to capture and analyze proteins in a sample. By analyzing the proteins, researchers can gain insights into the biological processes taking place within the sample. This makes it a valuable tool for Next-Generation Sequencing NGS which seeks to analyse a large number of samples quickly and efficiently.

Challenges

  • The Shortage of Experienced Professionals for Developing and Operating Protein Biochip- The Technology's complexity and the necessity of it highly specialized knowledge and skills to develop and operate protein biochips makes it difficult to find the right people with the necessary skills. That's making things difficult. Companies want to use the technology more widely. It also restricts the growth possibilities of the market.
  • Biochips are Expensive to Produce
  • Lack of Understanding Between People on the Subject Use of Protein Biochips for Potential Benefits

Protein Biochips Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

~15%

Base Year Market Size (2023)

~ USD 8 Billion

Forecast Year Market Size (2036)

~ USD 36 Billion

Regional Scope
  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Protein Biochips Segmentation

By Technology (Microarrays, Microfluidics)

The microarrays segment is estimated to hold 60% share of the global protein biochips market in the year 2036. The growth of the segment can be attributed to the increasing preference for microarrays owing to its ability to detect multiple biomarkers in a single assay, as well as its ability to generate higher throughput data compared to other technology-based protein biochips. Additionally, the rising demand for protein biochips for personalized medicine and drug discovery is also expected to contribute to the growth of the microarray segment. According to a study, there are 73,000 genetic testing products, and 250-300 personalized medicines that are currently available for cancer patients, genetic rare disease patients, and people with chronic and infectious diseases.

End-User (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centres, Academic & Research Institutes)

By end-user segment, the biotechnology & pharmaceutical companies’ market is expected to gain growth of 35% by the year 2036. The growth of this segment can be attributed to the increasing number of biotechnology companies, growth in the biopharmaceutical Industry and, increasing numbers of clinical trials for the development of innovative medicines and treatments. According to the US National Library of Medicine, there are 446,246 clinical trials taking place in all 50 states and in 221 countries as of March 2023. Furthermore, the advancement in technology capabilities is also enabling the development of more targeted and precision medicine and treatments, further stimulating the growth of the segment.

Our in-depth analysis of the global market includes the following segments:

 

                                  Technology

  • Microarrays
  • Microfluidics

                                  End-User
  • Biotechnology & Pharmaceutical Companies
  •  Hospitals & Diagnostics Centres
  •  Academic & Research Institutes

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Protein Biochips Industry - Regional Synopsis

North American Market Forecast

The protein biochips market in North America is projected to be the largest with a share of about 38% by the end of 2036. The growth of the market can be attributed majorly to the growing awareness among healthcare professionals regarding the various advantages associated with protein biochips. This includes better accuracy, sensitivity, and specificity of the results, as well as their ability to provide quick and reliable results. Moreover, the lack of access to proper healthcare and nutrition, as well as the prevalence of unhealthy lifestyle choices, has caused a dramatic increase in the number of people suffering from chronic diseases such as diabetes, hypertension, and heart disease in the region. As reported by the Centers for Disease Control and Prevention CDC, in 2022, 6 out of 10 adults in the United States had a chronic illness, while 4 out of 10 adults had two or more chronic illnesses.

Asia Pacific Market Statistics

The Asia Pacific protein biochips market is estimated to be the second largest, registering a share of about 27% by the end of 2036. The growth of the market can be attributed majorly to the increasing health consciousness among people and rising awareness of the benefits of protein-based functional food and beverages are some of the major factors driving the growth of the market. Moreover, the rapid growth in life sciences research activities in India, and China supported by biotechnology and pharmaceutical research, and low infrastructure costs are significant factors driving the development of protein biochip market in the APAC region.

Research Nester
Protein Biochips Market size
Get more information on this report: Request Free Sample PDF

Companies Dominating Protein Biochips Market

top-features-companies
    • Dynamic Biosensors GmbH
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
    • PerkinElmer Inc.
    • Bio-Rad Laboratories, Inc.
    • ABTECH Scientific, Inc.
    • Standard Bio Tools Inc.
    • Merck KGaA
    • LI-COR, Inc.
    • Cepheid
    • Nutcracker Therapeutics, Inc

In the News

  • Merck KGaA and Artios Pharma announced a global research collaboration that will lead to the development of multiple precision oncology drugs within the next three years. The collaboration will focus on the research of novel approaches to target cancer-causing mutations, with the goal of developing drugs that can be used to treat a variety of cancers.  
  • Bio-Rad Laboratories Inc, a global leader of life science research & clinical diagnostic products, announced the acquisition of Celsee, Inc., a company which offers instruments and consumables for the isolation, detection, and analysis of single cell.

Author Credits:  Radhika Pawar


  • Report ID: 3257
  • Published Date: Oct 03, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The increasing prevalence of chronic diseases and the growing demand for personalized medicine are creating a strong demand for protein biochips.

The market size of protein biochips is anticipated to attain a CAGR of 15% over the forecast period, i.e., 2024-2036.

High cost of the biochips and the lack of awareness among people about the potential benefits of using protein biochips are major factors that are slowing down the growth of the protein biochips market.

The market in the North America region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.

The major players in the market are Dynamic Biosensors GmbH, PerkinElmer Inc., Bio-Rad Laboratories, Inc., Illumina, Inc., ABTECH Scientific, Inc., Standard BioTools Inc., Merck KGaA, LI-COR, Inc., and others.
Protein Biochips Market Report Scope

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying